Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: J Pediatr. 2018 Sep 10;203:14–24.e2. doi: 10.1016/j.jpeds.2018.07.039

Figure 3: Mechanisms of therapy (molecular, epigenetic, and immunologic) for pediatric ALL.

Figure 3:

Precision medicine has revolutionized treatment of pediatric ALL by providing novel molecular and epigenetic targets, in addition to immunotherapeutic approaches to cure patients with relapsed/refractory disease.